CoChat
Sign Up
Cited by 2,002Muscle Physiology and DisordersWound Healing and TreatmentsImmune cells in cancer

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis

Open access
Arnold, Ludovic, Henry, Adeline, Poron, Françoise, Baba-Amer, Yasmine, van Rooijen, Nico, Plonquet, Anne, Gherardi, Romain K., Chazaud, Bénédicte·2007·The Journal of Experimental Medicine
DOI 10.1084/jem.20070075PMC PMC2118577
Open this paper in CoChat — free account

Abstract

Macrophages (MPs) are important for skeletal muscle regeneration in vivo and may exert beneficial effects on myogenic cell growth through mitogenic and antiapoptotic activities in vitro. However, MPs are highly versatile and may exert various, and even opposite, functions depending on their activation state. We studied monocyte (MO)/MP phenotypes and functions during skeletal muscle repair. Selective labeling of circulating MOs by latex beads in CX3CR1GFP/+ mice showed that injured muscle recruited only CX3CR1lo/Ly-6C+ MOs from blood that exhibited a nondividing, F4/80lo, proinflammatory profile. Then, within muscle, these cells switched their phenotype to become proliferating antiinflammatory CX3CR1hi/Ly-6C− cells that further differentiated into F4/80hi MPs. In vitro, phagocytosis of muscle cell debris induced a switch of proinflammatory MPs toward an antiinflammatory phenotype releasing transforming growth factor β1. In co-cultures, inflammatory MPs stimulated myogenic cell proliferation, whereas antiinflammatory MPs exhibited differentiating activity, assessed by both myogenin expression and fusion into myotubes. Finally, depletion of circulating MOs in CD11b–diphtheria toxin receptor mice at the time of injury totally prevented muscle regeneration, whereas depletion of intramuscular F4/80hi MPs at later stages reduced the diameter of regenerating fibers. In conclusion, injured skeletal muscle recruits MOs exhibiting inflammatory profiles that operate phagocytosis and rapidly convert to antiinflammatory MPs that stimulate myogenesis and fiber growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20070075

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Kinetics of MO/MP subsets during muscle regeneration in the CX3CR1GFP/+ mouse. (A) CD45+ cells present in injured muscle were analyzed for Ly-6C and GFP (CX3CR1) expression by flow cytometry. (top) Results are expressed as the percentage of CD45+ cells isolated from muscle and represent the means ± SD of three experiments. (bottom) Representative examples of FACS analysis at each time point. The two circles represent the two gated MO populations. (B) Total number of MOs/MPs was calculated from results obtained in A, and the number of isolated CD45+ cells were plotted to muscle weight. Results represent the means ± SD of three experiments. (C) Representative hematoxylin and eosin staining of muscle sections at various times after notexin injection. Bar, 50 μm.
Figure 1. Kinetics of MO/MP subsets during muscle regeneration in the CX3CR1GFP/+ mouse. (A) CD45+ cells present in injured muscle were analyzed for Ly-6C and GFP (CX3CR1) expression by flow cytometry. (top) Results are expressed as the percentage of CD45+ cells isolated from muscle and represent the means ± SD of three experiments. (bottom) Representative examples of FACS analysis at each time point. The two circles represent the two gated MO populations. (B) Total number of MOs/MPs was calculated from results obtained in A, and the number of isolated CD45+ cells were plotted to muscle weight. Results represent the means ± SD of three experiments. (C) Representative hematoxylin and eosin staining of muscle sections at various times after notexin injection. Bar, 50 μm.CC BY-NC-SA · PubMed Central
Figure 2. Phenotype of Ly-6C+ and Ly-6C− MOs/MPs during muscle regeneration. Ly-6C+ and Ly-6C− MO/MP subsets were isolated by cell sorting at various times after injury. (A) Representative example of cell sorting of Ly-6C− (middle) and Ly-6C+ (right) cells from whole MOs/MPs (left) at day 4 after injury. (B) Ki67 immunostaining is expressed as the percentage of isolated MOs/MPs. (C) Expression of TNF-α, IL-1β, TGF-β1, and IL-10 was analyzed by RT-PCR in isolated populations at day 4 after injury. Corresponding band intensities are given as the means of three experiments.
Figure 2. Phenotype of Ly-6C+ and Ly-6C− MOs/MPs during muscle regeneration. Ly-6C+ and Ly-6C− MO/MP subsets were isolated by cell sorting at various times after injury. (A) Representative example of cell sorting of Ly-6C− (middle) and Ly-6C+ (right) cells from whole MOs/MPs (left) at day 4 after injury. (B) Ki67 immunostaining is expressed as the percentage of isolated MOs/MPs. (C) Expression of TNF-α, IL-1β, TGF-β1, and IL-10 was analyzed by RT-PCR in isolated populations at day 4 after injury. Corresponding band intensities are given as the means of three experiments.CC BY-NC-SA · PubMed Central
Figure 3. Fate of Ly-6C+ and Ly-6C− MOs/MPs during muscle regeneration. (A) Circulating Ly-6C− (top) and Ly-6C+ (bottom) MOs were labeled with LX red microspheres and analyzed by flow cytometry. LX+ CD45+ GFP+ cells (gates in all cells; left) were analyzed for Ly-6C expression (LX+ cells; right) in both blood and muscle at day 3 (for Ly-6C− labeling) and day 2 (for Ly-6C+ labeling) after injury. Results are representative of three experiments. (B) SLPI and PPAR-γ expression was analyzed by RT-PCR in Ly-6C+ and Ly-6C− MOs/MPs sorted at day 4 after injury. (C) Flow cytometry analysis of forward scatter (FSC)/side scatter (SSC) characteristics, F4/80 and CD11c expression of Ly-6C+ (blue), and Ly-6C− (red) MOs/MPs sorted at day 7 after injury (black dotted line, isotypic control). Results are representative of three experiments.
Figure 3. Fate of Ly-6C+ and Ly-6C− MOs/MPs during muscle regeneration. (A) Circulating Ly-6C− (top) and Ly-6C+ (bottom) MOs were labeled with LX red microspheres and analyzed by flow cytometry. LX+ CD45+ GFP+ cells (gates in all cells; left) were analyzed for Ly-6C expression (LX+ cells; right) in both blood and muscle at day 3 (for Ly-6C− labeling) and day 2 (for Ly-6C+ labeling) after injury. Results are representative of three experiments. (B) SLPI and PPAR-γ expression was analyzed by RT-PCR in Ly-6C+ and Ly-6C− MOs/MPs sorted at day 4 after injury. (C) Flow cytometry analysis of forward scatter (FSC)/side scatter (SSC) characteristics, F4/80 and CD11c expression of Ly-6C+ (blue), and Ly-6C− (red) MOs/MPs sorted at day 7 after injury (black dotted line, isotypic control). Results are representative of three experiments.CC BY-NC-SA · PubMed Central
Figure 4. Phagocytosis and cytokine secretion by activated MPs. Cytokine secretion was evaluated by ELISA in MP-conditioned medium. (A) Cytokine secretion by untreated (NT) and LPS/IFN-γ–, IL-4–, and DEX/IL-10–treated MPs. (B) Cytokine secretion by untreated (NT) and LPS/IFN-γ– treated MPs after phagocytosis of muscle cell debris. (C, left) Phagocytosis of LXs by LPS/IFN-γ–treated MPs incubated or not (none) with colchicine (colc), cytochalasin D (cyt D), or recombinant Annexin V (Ann.V). (right) Cytokine secretion by LPS/IFN-γ–treated MPs after phagocytosis of muscle cell debris in the presence of the same effectors. Results represent the means ± SEM of three experiments.
Figure 4. Phagocytosis and cytokine secretion by activated MPs. Cytokine secretion was evaluated by ELISA in MP-conditioned medium. (A) Cytokine secretion by untreated (NT) and LPS/IFN-γ–, IL-4–, and DEX/IL-10–treated MPs. (B) Cytokine secretion by untreated (NT) and LPS/IFN-γ– treated MPs after phagocytosis of muscle cell debris. (C, left) Phagocytosis of LXs by LPS/IFN-γ–treated MPs incubated or not (none) with colchicine (colc), cytochalasin D (cyt D), or recombinant Annexin V (Ann.V). (right) Cytokine secretion by LPS/IFN-γ–treated MPs after phagocytosis of muscle cell debris in the presence of the same effectors. Results represent the means ± SEM of three experiments.CC BY-NC-SA · PubMed Central
Figure 5. Effects of activated MPs on mpc fate. mpcs were co-cultured with untreated (NT) and LPS/IFN-γ–, IL-4–, and DEX/IL-10–treated MPs and further analyzed for their (A) growth, (B) proliferation, (C) differentiation, and (D) fusion. All parameters were analyzed at day 3 of co-culture except for BrdU incorporation, which was monitored during 24 h of co-culture. Results represent the means ± SEM of three experiments. Asterisks above bars indicate significant differences (P < 0.05).
Figure 5. Effects of activated MPs on mpc fate. mpcs were co-cultured with untreated (NT) and LPS/IFN-γ–, IL-4–, and DEX/IL-10–treated MPs and further analyzed for their (A) growth, (B) proliferation, (C) differentiation, and (D) fusion. All parameters were analyzed at day 3 of co-culture except for BrdU incorporation, which was monitored during 24 h of co-culture. Results represent the means ± SEM of three experiments. Asterisks above bars indicate significant differences (P < 0.05).CC BY-NC-SA · PubMed Central
Figure 6. Effects of circulating MO depletion on skeletal muscle regeneration. (A, left) Kinetics of circulating MO depletion after one i.v. DT injection. Results represent the means ± SD of at least four experiments. (right) Examples of FACS analysis of blood before (−DT) and 18 h after i.v. DT injection (+DT). Circles show MO gate. (B–F) Notexin (Nx) was injected into the TA of CD11b-DTR mice at day 0, and DT was injected i.v. at various times, as indicated by the red arrows. Muscle histology was analyzed until day 7 after hematoxylin and eosin staining. Results are representative of at least two independent experiments. (F, inset) CD45+ cells were isolated from muscle and analyzed for F4/80 and CD11b expression 24 h after an i.v. DT (blue line) or PBS (red line) injection at day 4 after injury (black dotted line, isotypic control). Bar, 50 μm.
Figure 6. Effects of circulating MO depletion on skeletal muscle regeneration. (A, left) Kinetics of circulating MO depletion after one i.v. DT injection. Results represent the means ± SD of at least four experiments. (right) Examples of FACS analysis of blood before (−DT) and 18 h after i.v. DT injection (+DT). Circles show MO gate. (B–F) Notexin (Nx) was injected into the TA of CD11b-DTR mice at day 0, and DT was injected i.v. at various times, as indicated by the red arrows. Muscle histology was analyzed until day 7 after hematoxylin and eosin staining. Results are representative of at least two independent experiments. (F, inset) CD45+ cells were isolated from muscle and analyzed for F4/80 and CD11b expression 24 h after an i.v. DT (blue line) or PBS (red line) injection at day 4 after injury (black dotted line, isotypic control). Bar, 50 μm.CC BY-NC-SA · PubMed Central
Figure 7. Quantitative analysis of muscle regeneration after circulating MO depletion. CD11b-DTR mice were treated as in Fig. 6, and in each case the number of (A) necrotic myofibers, (B) phagocyted myofibers, (C) regenerating basic myofibers, and (D) centrally nucleated regenerating myofibers was evaluated. Closed squares represent the control corresponding to Fig. 6 B; open diamonds represent simultaneous DT and notexin injections corresponding to Fig. 6 C; open triangles represent a DT injection 12 h before notexin injection corresponding to Fig. 6 D; open squares represent a double DT injection corresponding to Fig. 6 E; and closed circles represent a DT injection 4 d after notexin injection corresponding to Fig. 6 F. Results are expressed as the percentage of total counted myofibers and are the means of at least two experiments.
Figure 7. Quantitative analysis of muscle regeneration after circulating MO depletion. CD11b-DTR mice were treated as in Fig. 6, and in each case the number of (A) necrotic myofibers, (B) phagocyted myofibers, (C) regenerating basic myofibers, and (D) centrally nucleated regenerating myofibers was evaluated. Closed squares represent the control corresponding to Fig. 6 B; open diamonds represent simultaneous DT and notexin injections corresponding to Fig. 6 C; open triangles represent a DT injection 12 h before notexin injection corresponding to Fig. 6 D; open squares represent a double DT injection corresponding to Fig. 6 E; and closed circles represent a DT injection 4 d after notexin injection corresponding to Fig. 6 F. Results are expressed as the percentage of total counted myofibers and are the means of at least two experiments.CC BY-NC-SA · PubMed Central
Figure 8. Effects of i.m. DT injection on skeletal muscle regeneration. Notexin (Nx) was injected into the TA of CD11b-DTR mice at day 0, and DT was injected in the same muscle at day 5 (A) and days 5 and 6 (B and C). (A) 24 h after a single i.m. DT injection, CD45+ cells were isolated from muscle and analyzed for F4/80 expression. Red circles enclose FSChi/F4/80hi cells. (B) Reconstituted whole view of TA muscle at day 10 after Notexin injection (hematoxylin and eosin staining), presenting hallmarks of secondary regeneration restricted to the site of needle puncture (arrow). (right) Hatched area represents the area excluded from analysis. Bar, 200 μm. (C) PBS- and DT-injected muscles were analyzed at day 10 after injury for myofiber diameter evaluation (hematoxylin and eosin staining). Quantified results are given for three independent experiments, with each point corresponding to a field (red bars represent the means). Bar, 50 μm.
Figure 8. Effects of i.m. DT injection on skeletal muscle regeneration. Notexin (Nx) was injected into the TA of CD11b-DTR mice at day 0, and DT was injected in the same muscle at day 5 (A) and days 5 and 6 (B and C). (A) 24 h after a single i.m. DT injection, CD45+ cells were isolated from muscle and analyzed for F4/80 expression. Red circles enclose FSChi/F4/80hi cells. (B) Reconstituted whole view of TA muscle at day 10 after Notexin injection (hematoxylin and eosin staining), presenting hallmarks of secondary regeneration restricted to the site of needle puncture (arrow). (right) Hatched area represents the area excluded from analysis. Bar, 200 μm. (C) PBS- and DT-injected muscles were analyzed at day 10 after injury for myofiber diameter evaluation (hematoxylin and eosin staining). Quantified results are given for three independent experiments, with each point corresponding to a field (red bars represent the means). Bar, 50 μm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Research works printed but not linked: 5

  1. 1996, J. Anat., 188, 17
  2. 2006, J. Leukoc. Biol., 81, 775
  3. 2004, FASEB J., 19, 413
  4. 2006, Nat. Immunol., 7, 265
  5. 2004, Proc. Natl. Acad. Sci. USA., 102, 99

Cited by

Sorted by citations

Items 901–1,000 of 1,001

Related

See all

Metadata

Authors
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B.
Affiliations
  • Inserm (FR)
  • Université Paris-Est Créteil (FR)
  • 1Institut National de la Santé et de la Recherche Médicale, Unité 841, Institut Mondor de Recherche Biomédicale, “Cell Interactions in the Neuromuscular System” Team, Université Paris 12 Val-de-Marne, 94000 Créteil, France
  • Vrije Universiteit Amsterdam (NL)
  • Assistance Publique – Hôpitaux de Paris (FR)
ORCID
Venue
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Published
2007-05-07
Volume
204
Issue
5
Pages
1057-1069
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
DOI
10.1084/jem.20070075
PMC
PMC2118577
OpenAlex
W2108723188
Cited by
2,002
References
82
Citations by year
2026: 87 · 2025: 83 · 2024: 100 · 2023: 119 · 2022: 124 · 2021: 151 · 2020: 144 · 2019: 134 · 2018: 131 · 2017: 147 · 2016: 119 · 2015: 127 · 2014: 120 · 2013: 101 · 2012: 89
FWCI
20.15
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
Institut National de la Santé et de la Recherche Médicale
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
inflammatory monocytes, macrophage polarization, skeletal muscle regeneration, myogenesis, CX3CR1, Ly6C, F4/80, TGF-β1, myotube formation, monocyte depletion, muscle damage
MeSH terms
CX3C Chemokine Receptor 1, Animals, Cell Differentiation, Humans, Immunohistochemistry, Macrophages, Mice, Mutant Strains, Microspheres, Monocytes, Phagocytosis, DNA Primers, Muscle, Skeletal, Receptors, Chemokine, Reverse Transcriptase Polymerase Chain Reaction, Muscle Development, CD11b Antigen, Green Fluorescent Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review